HSB-9646

N/A

Report date: 2023/09/18 10:44:36

Base Information

Drug NameHSB-9646

Drug Alias NameHSB-9646

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionProgrammed cell death protein 1 modulators

TargetsProgrammed cell death protein 1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTharimmune Inc

China Registration ClassN/A

Develop Information

Active CompaniesTharimmune Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A